Clinical Trial Update: Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the effect of GW876008 on cerebral blood flow in irritable bowel syndrome patients and healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• GW876008

Snippet

Sponsor: GlaxoSmithKline | Conditions: Irritable Colon, Irritable Bowel Syndrome (IBS) | Phase 1 | Status: COMPLETED